BARTOLOMEI, MIRCO
 Distribuzione geografica
Continente #
NA - Nord America 1.360
AS - Asia 715
EU - Europa 631
SA - Sud America 137
AF - Africa 14
OC - Oceania 9
Totale 2.866
Nazione #
US - Stati Uniti d'America 1.335
SG - Singapore 358
IT - Italia 184
CN - Cina 172
PL - Polonia 141
BR - Brasile 127
DE - Germania 79
GB - Regno Unito 48
TR - Turchia 37
UA - Ucraina 37
SE - Svezia 33
ID - Indonesia 30
FI - Finlandia 22
IR - Iran 22
CA - Canada 19
BE - Belgio 18
KR - Corea 18
IN - India 14
HK - Hong Kong 13
NL - Olanda 13
AT - Austria 12
AU - Australia 9
JP - Giappone 8
TH - Thailandia 8
FR - Francia 7
LT - Lituania 7
VN - Vietnam 7
MY - Malesia 5
RU - Federazione Russa 5
ZA - Sudafrica 5
IE - Irlanda 4
IQ - Iraq 4
MX - Messico 4
RO - Romania 4
AR - Argentina 3
DZ - Algeria 3
EE - Estonia 3
ES - Italia 3
PH - Filippine 3
PK - Pakistan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PT - Portogallo 2
QA - Qatar 2
TW - Taiwan 2
VE - Venezuela 2
ZM - Zambia 2
BN - Brunei Darussalam 1
BO - Bolivia 1
EC - Ecuador 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
Totale 2.866
Città #
Chandler 149
Singapore 138
Warsaw 136
Santa Clara 133
Fairfield 124
Ashburn 89
Ann Arbor 78
Woodbridge 57
Wilmington 48
Jacksonville 45
Seattle 40
Houston 39
Beijing 34
Izmir 32
Shanghai 28
Ferrara 26
Cambridge 25
Jakarta 25
Addison 23
Nanjing 22
Princeton 21
The Dalles 18
Brussels 17
Helsinki 17
Milan 17
New York 17
Boardman 15
Bologna 14
Dearborn 14
Hong Kong 13
Falls Church 12
Los Angeles 12
San Diego 11
Frankfurt am Main 10
London 10
Redwood City 10
Rome 10
Toronto 10
Chengdu 9
Munich 9
São Paulo 9
Belo Horizonte 8
Bremen 8
Buriram 8
Nanchang 8
Nuremberg 8
San Mateo 8
Sydney 8
Wuhan 8
Augusta 7
Ferrara di Monte Baldo 7
Chongqing 6
Leawood 6
Monmouth Junction 6
Mountain View 6
Rio de Janeiro 6
Shenyang 6
Ardabil 5
Brasília 5
Ottawa 5
Padova 5
Washington 5
Cattolica 4
Changsha 4
Dong Ket 4
Falkenstein 4
Geumcheon-gu 4
Hangzhou 4
Kuala Lumpur 4
Lappeenranta 4
Maceió 4
Monza 4
Reggio Nell'emilia 4
Tianjin 4
Vienna 4
Cagliari 3
Changchun 3
Düsseldorf 3
Forlì 3
Isfahan 3
Istanbul 3
Jiaxing 3
Kochi 3
Mcallen 3
Mestre 3
Parma 3
Philadelphia 3
Tashkent 3
Zhengzhou 3
Amsterdam 2
Assago 2
Atlanta 2
Buenos Aires 2
Campinas 2
Cape Town 2
Chandigarh 2
Chicago 2
Council Bluffs 2
Cuiabá 2
Dallas 2
Totale 1.821
Nome #
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 216
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 152
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 144
The impact of FDG and amyloid PET-CT in a clinical setting consisting of patients with suspected dementia: the Ferrara experience 143
Technical aspects related to different reconstruction algorithms in FDG PET-CT imaging: a correlation study between SUVmax and volume in neoplastic lesions 130
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 119
Comparison of 18F-FDG vs "early phase" 18F-Florbetapir brain distribution in patients with suspected or known neurodegenerative disease 117
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 107
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 107
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 105
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 103
Lymphoscintigraphy (LS) of Oral Cavity Cancer (OCC) as tool for surgical customization for a selective and modified lymphadenectomy: preliminary report 98
Radioembolisation with 90Y-microspheres: Dosimetric and radiobiological investigation for multi-cycle treatment 93
Impact of (18)F-Fluoro-Methyl-Choline (FMC) PET/CT in the detection of recurrent prostate cancer: correlation with PSA kinetics and Radiological Imaging. 93
The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in suspected recovery of breast cancer disease: comparison with Radiological Imaging and impact on patient management 91
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 91
Erratum: Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 87
Dosimetry for treatment with radiolabelled somatostatin analogues. A review 84
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 78
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 75
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 74
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 71
Lymphoscintigraphy and radio-guided neck dissection in oral cavity squamous cell carcinoma 66
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 58
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 55
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 43
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 42
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 41
Clinical platforms in NET patients treated with radioligand therapy: a dosimetric comparison 38
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 36
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 36
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 30
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 30
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 26
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 23
18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients 21
Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy 12
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 11
Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 9
Totale 2.955
Categoria #
all - tutte 18.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 0 0 0 0 0 22 10
2020/2021426 17 35 69 61 17 41 22 32 12 34 55 31
2021/2022254 13 16 20 25 19 13 12 19 7 26 12 72
2022/2023334 29 44 9 46 42 37 13 33 38 6 30 7
2023/2024282 16 26 23 10 24 47 7 41 5 15 14 54
2024/20251.058 45 38 100 69 170 109 76 74 225 128 24 0
Totale 2.955